Introduction: To evaluate the safety and efficacy of the TiLOOP® male sling (pfm medical, Cologne, Germany) used in the treatment for male stress urinary incontinence (SUI). Material and Methods: We retrospectively evaluated a total of 34 patients with a TiLOOP® male sling. Perioperative complication rates were assessed and validated questionnaires were prospectively evaluated to assess quality of life and satisfaction rate. Outcome and complication rates were analysed by using descriptive statistics. Correlation of continence outcome and risk factors was performed with the chi-square test. A p value below 0.05 was considered statistically significant. Results: The majority of patients (70.6%) were diagnosed with mild or moderate male SUI. During surgery, one instance (2.9%) of intraoperative urethral injury was observed. There were no immediate postoperative complications. The mean follow-up time was 44.6 months. An improvement of male SUI was reported by 61.9% of the patients and 38.1% reported no change according the Patient Global Impression of Improvement. The mean perineal pain score was 0.5 according to the international index of pain. Conclusions: The TiLOOP® is a safe treatment option for male SUI in our cohort with a low complication rate. However, the functional outcome of the TiLOOP® was inferior when compared to the outcome of the AdVance® male sling.

1.
Lucas MG, Bosch RJ, Burkhard FC, Cruz F, Madden TB, Nambiar AK, Neisius A, de Ridder DJ, Tubaro A, Turner WH, Pickard RS: Eau guidelines on surgical treatment of urinary incontinence. Actas Urol Esp 2013;37:459-472.
2.
Hampel C, Gillitzer R, Wiesner C, Thuroff JW: [Established treatment options for male stress urinary incontinence]. Urologe A 2007;46:244-248, 250-246.
3.
Bauer RM, Oelke M, Hubner W, Grabbert M, Kirschner-Hermanns R, Anding R: [Urinary incontinence in men]. Urologe A 2015;54:887-899; quiz 900.
4.
Cornu JN, Sebe P, Ciofu C, Peyrat L, Cussenot O, Haab F: Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int 2011;108:236-240.
5.
Rehder P, Mitterberger MJ, Pichler R, Kerschbaumer A, Glodny B: The 1 year outcome of the transobturator retroluminal repositioning sling in the treatment of male stress urinary incontinence. BJU Int 2010;106:1668-1672.
6.
Scheidbach H, Tannapfel A, Schmidt U, Lippert H, Kockerling F: Influence of titanium coating on the biocompatibility of a heavyweight polypropylene mesh. An animal experimental model. Eur Surg Res 2004;36:313-317.
7.
Dieterich M, Stubert J, Gerber B, Reimer T, Richter DU: Biocompatibility, cell growth and clinical relevance of synthetic meshes and biological matrixes for internal support in implant-based breast reconstruction. Arch Gynecol Obstet 2015;291:1371-1379.
8.
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP: Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996;47:67-71; discussion 71-72.
9.
Yalcin I, Bump RC: Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003;189:98-101.
10.
Seckiner I, Yesilli C, Mungan NA, Aykanat A, Akduman B: Correlations between the ICIQ-SF score and urodynamic findings. Neurourol Urodyn 2007;26:492-494.
11.
Twiss CO, Fischer MC, Nitti VW: Comparison between reduction in 24-hour pad weight, international consultation on incontinence-short form (ICIQ-SF) score, international prostate symptom score (IPSS), and post-operative patient global impression of improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn 2007;26:8-13.
12.
de Leval J, Waltregny D: The inside-out trans-obturator sling: a novel surgical technique for the treatment of male urinary incontinence. Eur Urol 2008;54:1051-1065.
13.
Bauer RM, Gozzi C, Klehr B, Kretschmer A, Grabbert M, Rehder P, May F, Stief CG, Gebhartl P, Homberg R: Advancexp male sling: 2-year results of a multicentre study. World J Urol 2015;34:1025-1030.
14.
Sacco E, Bientinesi R, Recupero S, Racioppi M, Pinto F, Gulino G, Palermo G, D'Agostino D, Bassi P: Evaluation of safety, tolerability and efficacy of tiloop®, a titanized inside-out transobturatory sling for male stress urinary incontinence. Annual Meeting of the International Continence Society (ICS). Montreal, 2015.
15.
Crivellaro S, Morlacco A, Bodo G, Agro EF, Gozzi C, Pistolesi D, Del Popolo G, Ficarra V: Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. Neurourol Urodyn 2016;35:875-881.
16.
Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM: Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol 2012;62:140-145.
17.
Collado Serra A, Resel Folkersma L, Dominguez-Escrig JL, Gomez-Ferrer A, Rubio-Briones J, Solsona Narbon E: Advance/advance xp transobturator male slings: Preoperative degree of incontinence as predictor of surgical outcome. Urology 2013;81:1034-1039.
18.
Bauer RM, Kretschmer A, Stief CG, Fullhase C: Advance and advance xp slings for the treatment of post-prostatectomy incontinence. World J Urol 2015;33:145-150.
19.
Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hubner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Bauer RM, Haferkamp A: Risk factors for failure of male slings and artificial urinary sphincters: results from a large middle European cohort study. Urol Int 2016, Epub ahead of print.
20.
Leruth J, Waltregny D, de Leval J: The inside-out transobturator male sling for the surgical treatment of stress urinary incontinence after radical prostatectomy: midterm results of a single-center prospective study. Eur Urol 2012;61:608-615.
21.
Bauer RM, Mayer ME, Gratzke C, Soljanik I, Buchner A, Bastian PJ, Stief CG, Gozzi C: Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year. Eur Urol 2009;56:928-933.
22.
Bauer RM, Mayer ME, May F, Gratzke C, Buchner A, Soljanik I, Bastian PJ, Stief CG, Gozzi C: Complications of the advance transobturator male sling in the treatment of male stress urinary incontinence. Urology 2010;75:1494-1498.
23.
Harris SE, Guralnick ML, O'Connor RC: Urethral erosion of transobturator male sling. Urology 2009;73:443.e419-e420.
24.
Rehder P: Re: Harris SE, Guralnick ML, O'connor RC: Urethral erosion of transobturator male sling. (urology 2009;73:443). Urology 2009;73:449-450; author reply 450.
25.
Staat M, Trenz E, Lohmann P, Frotscher R, Klinge U, Tabaza R, Kirschner-Hermanns R: New measurements to compare soft tissue anchoring systems in pelvic floor surgery. J Biomed Mater Res B Appl Biomater 2012;100:924-933.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.